Notably, the sensitization to death receptor-induced apoptosis appears to be a general phenomenon affecting more than a single clone of cisplatin-resistant cells; heterogeneous cisplatin-resistant clones derived from NSCLC and ovarian cancer are equally susceptible to such resensitization properties of TRAIL (Supplementary Figure S8). This evidence concerns the gene TNFSF10 and non-small cell lung carcinoma.